TKI and checkpoint inhibitor combinations for kidney cancer: the IMmotion151 trial
The current standard of care for frontline kidney cancer is tyrosine kinase inhibitor (TKI) treatment. Now there are a host of promising immune checkpoint inhibitors in trials for this indication, eit...
Author: VJOncology
Added: 02/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Systemic Therapy in Metastatic Renal Cell Carcinoma Antibiotic use does affect outcomes in patients
Aly-Khan Lalani, MD from Dana-Farber Cancer Institute discusses the Systemic Therapy in Metastatic Renal Cell Carcinoma Antibiotic use does affect outcomes in patients at the 2018 ASCO.
Author: Genitourinary-Cancer-Meeting
Added: 02/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment of metastatic renal cell carcinoma (mRCC) in the elderly
Neeraj Agarwal, MD Associate Professor of Medicine Director, Genitourinary Oncology Co-leader, Urologic Oncology Multidisciplinary Program Huntsman Cancer Institute, University of Utah discusses the t...
Author: kidneycancer
Added: 11/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 11, 2017 Category: Cancer & Oncology Source Type: podcasts
Renal Medullary Carcinoma
Pavlos Msaouel MD, PhD Chief Fellow, Hematology/Oncology MD Anderson Cancer Center discusses Renal Medullary Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL. <br />
Author: kidneycancer
Added: 11/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 11, 2017 Category: Cancer & Oncology Source Type: podcasts
Challenging Cases 2017 Kidney Cancer Association Symposium
Christopher Wood, MD, Elizabeth Plimack, MD, Martin Voss, MD, Viraj Masters, MD, A. Ari Hakimi, MD consult on a several real world challenge kidney cancer cases at the 2017 Kidney Cancer Association s...
Author: kidneycancer
Added: 11/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Integrated Biomarker Analysis for 412 RCC patients Treated on the Phase 3 COMPARZ Trial
Martin Voss, MD Memorial Sloan Kettering discusses Integrated Biomarker Analysis for 412 RCC patients Treated on the Phase 3 COMPARZ Trial at the 2017 Kidney Cancer Association symposium in Miami, FL....
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
IMmotion150: Novel Radiological Endpoints and Updated Data From a Randomized Phase II Trial Investigating Atezolizumab With or Without Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma
Sumanta Kumar Pal, M.D City of Hope Cancer Center discusses IMmotion150: Novel Radiological Endpoints and Updated Data From a Randomized Phase II Trial Investigating Atezolizumab With or Without Bevac...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Comparative GenomicProfilingofMatched Primary and Metastatic Tumors in Renal Cell Carcinoma
Comparative GenomicProfilingofMatched Maria Becerra, MD discusses Primary and Metastatic Tumors in Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL. <br />
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Clinical Activity of Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma
Vadim S. Koshkin, MD Cleveland Clinic Taussig Cancer discusses Clinical Activity of Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in M...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Training Urologists To Be Experts In Renal Cell Carcinoma
Christopher G. Wood, M. D., FACS Professor and Deputy Chairman Douglas E. Johnson, M. D. Endowed Professorship In Urology Department of Urology The University of Texas MD Anderson Cancer Center outlin...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Training Medical Oncologists to be Experts in RCC
Ronald M. Bukowski, MD discusses Training Medical Oncologists to be Experts in RCC at the 2017 Kidney Cancer Association symposium in Miami, FL. <br />
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Update on Genomic Classifiers in RCC
Martin Voss, MD Genitourinary Oncology Service Memorial Sloan Kettering Cancer Center, New York gives an Update on Genomic Classifiers in RCC at the 2017 Kidney Cancer Association symposium in Miami, ...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
Circulating Biomarkers in Clear Cell Renal Cell Carcinoma
Joshua M. Lang, MD University of Wisconsin School of Medicine and Public Health discusses Circulating Biomarkers in Clear Cell Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in ...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
